Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer.
Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer.
复制标题
DOI:
10.1093/nar/gky396
复制
发表时间:
2018-09-06
影响因子:
14.9
通讯作者:
Chen L
中科院分区:
文献类型:
--
作者:
Hong H;An O;Chan THM;Ng VHE;Kwok HS;Lin JS;Qi L;Han J;Tay DJT;Tang SJ;Yang H;Song Y;Bellido Molias F;Tenen DG;Chen L
Adenosine-to-inosine (A-to-I) RNA editing entails the enzymatic deamination of adenosines to inosines by adenosine deaminases acting on RNA (ADARs). Dysregulated A-to-I editing has been implicated in various diseases, including cancers. However, the precise factors governing the A-to-I editing and their physiopathological implications remain as a long-standing question. Herein, we unravel that DEAH box helicase 9 (DHX9), at least partially dependent of its helicase activity, functions as a bidirectional regulator of A-to-I editing in cancer cells. Intriguingly, the ADAR substrate specificity determines the opposing effects of DHX9 on editing as DHX9 silencing preferentially represses editing of ADAR1-specific substrates, whereas augments ADAR2-specific substrate editing. Analysis of 11 cancer types from The Cancer Genome Atlas (TCGA) reveals a striking overexpression of DHX9 in tumors. Further, tumorigenicity studies demonstrate a helicase-dependent oncogenic role of DHX9 in cancer development. In sum, DHX9 constitutes a bidirectional regulatory mode in A-to-I editing, which is in part responsible for the dysregulated editome profile in cancer.
登录
查看更多内容
影响因子:
48
作者:
Langmead, Ben;Salzberg, Steven L.
通讯作者:
Salzberg, Steven L.
影响因子:
64.8
作者:
Aktas, Tugce;Ilik, Ibrahim Avsar;Akhtar, Asifa
通讯作者:
Akhtar, Asifa
影响因子:
4.8
作者:
Chilibeck, Kaari A.;Wu, Tao;MacMillan, Andrew M.
通讯作者:
MacMillan, Andrew M.
影响因子:
5.6
作者:
Lehmann, KA;Bass, BL
通讯作者:
Bass, BL
影响因子:
4.8
作者:
Cenci, Caterina;Barzotti, Rita;Gallo, Angela
通讯作者:
Gallo, Angela